A detailed history of Excalibur Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Excalibur Management Corp holds 14,057 shares of ABBV stock, worth $2.83 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
14,057
Previous 13,902 1.11%
Holding current value
$2.83 Million
Previous $2.53 Million 4.74%
% of portfolio
0.99%
Previous 1.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $23,992 - $28,017
155 Added 1.11%
14,057 $2.41 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $15,502 - $17,663
-97 Reduced 0.69%
13,902 $2.53 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $825 - $929
-6 Reduced 0.04%
13,999 $2.17 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $25,649 - $29,692
192 Added 1.39%
14,005 $2.09 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $8,745 - $10,883
66 Added 0.48%
13,813 $1.86 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $19,377 - $22,316
-134 Reduced 0.97%
13,747 $2.19 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $13,277 - $15,923
-96 Reduced 0.69%
13,881 $2.24 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $3,355 - $3,848
25 Added 0.18%
13,977 $1.88 Million
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $303,452 - $385,786
-2,205 Reduced 13.65%
13,952 $2.14 Million
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $105,056 - $130,345
796 Added 5.18%
16,157 $2.62 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $32,443 - $41,050
302 Added 2.01%
15,361 $2.08 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $10,852 - $12,319
102 Added 0.68%
15,059 $1.62 Million
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $10,521 - $11,721
-100 Reduced 0.66%
14,957 $1.69 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $85,727 - $94,375
838 Added 5.89%
15,057 $1.63 Million
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $317,211 - $428,268
3,941 Added 38.34%
14,219 $1.52 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $3,436 - $4,033
40 Added 0.39%
10,278 $900,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $86,136 - $115,263
1,174 Added 12.95%
10,238 $1.01 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $542,574 - $822,609
-8,412 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $416,190 - $520,742
5,770 Added 218.4%
8,412 $745,000
Q3 2019

Oct 21, 2019

BUY
$62.98 - $75.72 $166,393 - $200,052
2,642 New
2,642 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Excalibur Management Corp Portfolio

Follow Excalibur Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.